Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis.

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis.

Lung pathology in cystic fibrosis is linked to dehydration of the airways epithelial surface which in part results from inappropriately raised sodium reabsorption through the epithelial sodium channel (ENaC). To identify a small-interfering RNA (siRNA) which selectively inhibits ENaC expression, che...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Clark, K, Hughes, SA, Bulsara, P, Coates, J, Moores, K, Parry, J, Carr, M, Mayer, R, Wilson, P, Gruenloh, C, Levin, D, Darton, J, Weber, WM, Sobczak, K, Gill, DR, Hyde, S, Davies, L, Pringle, I, Sumner-Jones, S, Jadhav, V, Jamison, S, Strapps, W, Pickering, V, Edbrooke, MR
Materialtyp: Journal article
Språk:English
Publicerad: 2013

Liknande verk

Liknande verk